Identification of SARS-CoV-2-specific immune alterations in acutely ill patients

Rose-Marie Rebillard; Marc Charabati; Camille Grasmuck; Abdelali Filali-Mouhim; Olivier Tastet; Nathalie Brassard; Audrey Daigneault; Lyne Bourbonniere; Renaud Balthazard; Ana Carmena Moratalla; Yves Carpentier Solorio; Negar Farzam-kia; Antoine Philippe Fournier; Elizabeth Gowing; Helene Jamann; Florent Lemaitre; Victoria Hannah Mamane; Karine Thai; Jean-Franois Cailhier; Nicolas Chomont; Andres Finzi; Michael Chasse; Madeleine Durand; Nathalie Arbour; Daniel E Kaufmann; Alexandre Prat; Catherine Larochelle.
Preprint en Inglés | PREPRINT-MEDRXIV | ID: ppmedrxiv-20248642

Documentos relacionados

  1. Identification of SARS-CoV-2-specific immune alterations in acutely ill patients.
  2. Extensive acute and sustained changes to neutrophil proteomes post-SARS-CoV-2 infection.
  3. Increased Peripheral Blood Neutrophil Activation Phenotypes and Neutrophil Extracellular Trap Formation in Critically Ill Coronavirus Disease 2019 (COVID-19) Patients: A Case Series and Review of the Literature.
  4. Iron dysregulation and inflammatory stress erythropoiesis associates with long-term outcome of COVID-19.
  5. Hyperinflammatory environment drives dysfunctional myeloid cell effector response to bacterial challenge in COVID-19.
  6. Serum VEGF-A levels on admission in COVID-19 patients correlate with SP-D and neutrophils, reflecting disease severity: A prospective study.
  7. Impairment of neutrophil functions and homeostasis in COVID-19 patients: association with disease severity.
  8. Relationship between gene expression patterns from nasopharyngeal swabs and serum biomarkers in patients hospitalized with COVID-19, following treatment with the neutralizing monoclonal antibody bamlanivimab.
  9. What SARS-CoV-2 does to our brains.
  10. In vivo structural characterization of the SARS-CoV-2 RNA genome identifies host proteins vulnerable to repurposed drugs.